GeneDx Holdings (WGS) Non-Current Assets (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Non-Current Assets of $235.7 million for Q1 2026, up 6.83% YoY from $220.6 million in Q1 2025, and down 7.73% sequentially from $255.4 million in Q4 2025.
GeneDx Holdings (WGS) Non-Current Assets (2020 - 2026) Analysis & Trends
GeneDx Holdings has disclosed Non-Current Assets across 7 years of filings, most recently posting $235.7 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 6.83% year-over-year to $235.7 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 12.86% YoY), while the FY2025 annual figure was $255.4 million, up 15.36% from the prior year.
- Non-Current Assets retreated to $235.7 million in Q1 2026, from $255.4 million in the prior quarter.
- Over the last five years, Non-Current Assets for WGS reached as high as $530.6 million in Q2 2022 and fell as low as $107.2 million in Q1 2022.
- The 5-year median for Non-Current Assets is $245.5 million (2023), against an average of $269.8 million.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 705.55% — and 2023, when it plunged 53.01%.
- A 5-year view of Non-Current Assets shows it stood at $278.3 million in 2022, then decreased by 15.06% to $236.4 million in 2023, then retreated by 6.35% to $221.4 million in 2024, then rose by 15.36% to $255.4 million in 2025, then dropped by 7.73% to $235.7 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $235.7 million, $255.4 million, and $256.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 20.47 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 90.97 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 69.61 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 1.93 Bn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 962.59 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 8.30 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 23.46 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 3.82 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 2.34 Bn |
| 10 | GeneDx Holdings | 2.10 Bn | 1.93 Bn | 68.21 Mn | 235.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235.67 Mn |
| Dec 31, 2025 | 255.42 Mn |
| Sep 30, 2025 | 256.32 Mn |
| Jun 30, 2025 | 259.03 Mn |
| Mar 31, 2025 | 220.61 Mn |
| Dec 31, 2024 | 221.41 Mn |
| Sep 30, 2024 | 222.83 Mn |
| Jun 30, 2024 | 226.93 Mn |
| Mar 31, 2024 | 231.10 Mn |
| Dec 31, 2023 | 236.42 Mn |
| Sep 30, 2023 | 245.47 Mn |
| Jun 30, 2023 | 263.11 Mn |
| Mar 31, 2023 | 272.95 Mn |
| Dec 31, 2022 | 278.32 Mn |
| Sep 30, 2022 | 522.36 Mn |
| Jun 30, 2022 | 530.58 Mn |
| Mar 31, 2022 | 107.25 Mn |
| Dec 31, 2021 | 70.55 Mn |
| Sep 30, 2021 | 64.85 Mn |
| Jun 30, 2021 | 76.52 Mn |